271 related articles for article (PubMed ID: 33092592)
41. Interventions for promoting habitual exercise in people living with and beyond cancer.
Turner RR; Steed L; Quirk H; Greasley RU; Saxton JM; Taylor SJ; Rosario DJ; Thaha MA; Bourke L
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD010192. PubMed ID: 30229557
[TBL] [Abstract][Full Text] [Related]
42. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
43. Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.
Plöthner M; Ribbentrop D; Hartman JP; Frank M
Adv Ther; 2016 Sep; 33(9):1461-80. PubMed ID: 27406232
[TBL] [Abstract][Full Text] [Related]
44. Factors Explaining Socio-Economic Inequalities in Cancer Survival: A Systematic Review.
Afshar N; English DR; Milne RL
Cancer Control; 2021; 28():10732748211011956. PubMed ID: 33929888
[TBL] [Abstract][Full Text] [Related]
45. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
46. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
47. Challenges in the clinical implementation of precision medicine companion diagnostics.
Keeling P; Clark J; Finucane S
Expert Rev Mol Diagn; 2020 Jun; 20(6):593-599. PubMed ID: 32336167
[TBL] [Abstract][Full Text] [Related]
48. Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Sati N; Boyne DJ; Cheung WY; Cash SB; Arora P
JAMA Netw Open; 2021 Jan; 4(1):e2034201. PubMed ID: 33496794
[TBL] [Abstract][Full Text] [Related]
49. Socioeconomic status and oral health-related quality of life: A systematic review and meta-analysis.
Knorst JK; Sfreddo CS; de F Meira G; Zanatta FB; Vettore MV; Ardenghi TM
Community Dent Oral Epidemiol; 2021 Apr; 49(2):95-102. PubMed ID: 33368600
[TBL] [Abstract][Full Text] [Related]
50. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
51. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
[TBL] [Abstract][Full Text] [Related]
52. Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries.
Hirsch FR; Zaric B; Rabea A; Thongprasert S; Lertprasertsuke N; Dalurzo ML; Varella-Garcia M
Am Soc Clin Oncol Educ Book; 2017; 37():403-408. PubMed ID: 28561679
[TBL] [Abstract][Full Text] [Related]
53. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE.
Beynon R; Leeflang MM; McDonald S; Eisinga A; Mitchell RL; Whiting P; Glanville JM
Cochrane Database Syst Rev; 2013 Sep; 2013(9):MR000022. PubMed ID: 24022476
[TBL] [Abstract][Full Text] [Related]
54. Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li Y; Ma Y; Wu Z; Zeng F; Song B; Zhang Y; Li J; Lui S; Wu M
Front Immunol; 2021; 12():751407. PubMed ID: 34659255
[TBL] [Abstract][Full Text] [Related]
55. Deployment of personnel to military operations: impact on mental health and social functioning.
Bøg M; Filges T; Jørgensen AMK
Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
[TBL] [Abstract][Full Text] [Related]
56. Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer.
Shinde R; Cao X; Kothari S
J Manag Care Spec Pharm; 2016 Oct; 22(10):1194-203. PubMed ID: 27668568
[TBL] [Abstract][Full Text] [Related]
57. Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
Albaba H; Lim C; Leighl NB
Pharmacoeconomics; 2017 Dec; 35(12):1195-1209. PubMed ID: 28861770
[TBL] [Abstract][Full Text] [Related]
58. Management of frozen shoulder: a systematic review and cost-effectiveness analysis.
Maund E; Craig D; Suekarran S; Neilson A; Wright K; Brealey S; Dennis L; Goodchild L; Hanchard N; Rangan A; Richardson G; Robertson J; McDaid C
Health Technol Assess; 2012; 16(11):1-264. PubMed ID: 22405512
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
